Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL124322 | 0.83 | ALDH1A1 (0.49) | ALDH1A1CYP3A4L3MBTL1TSHRTDP1 | |
| SCHEMBL16248503 | 0.82 | ALDH1A1 (0.51) | ALDH1A1CYP3A4L3MBTL1TSHRTDP1 | |
| SCHEMBL4960871 | 0.81 | ALDH1A1 (0.42) | ALDH1A1CYP3A4L3MBTL1TSHRTDP1 | |
| SCHEMBL27639169 | 0.77 | ALDH1A1 (0.50) | ALDH1A1CYP3A4L3MBTL1TSHRTDP1 | |
| SCHEMBL19105133 | 0.77 | ALDH1A1 (0.43) | ALDH1A1CYP3A4L3MBTL1TSHRTDP1 | |
| SCHEMBL27639170 | 0.76 | ALDH1A1 (0.49) | ALDH1A1CYP3A4L3MBTL1TSHRTDP1 | |
| SCHEMBL27785670 | 0.75 | ALDH1A1 (0.44) | ALDH1A1CYP3A4L3MBTL1TSHRTDP1 | |
| SCHEMBL80432 | 0.74 | CYP3A4 (0.67) | ALDH1A1CYP3A4L3MBTL1TSHRTDP1 | |
| SCHEMBL13706989 | 0.74 | CYP3A4 (0.33) | CYP3A4 | |
| SCHEMBL4890028 | 0.74 | CYP3A4 (0.50) | ALDH1A1CYP3A4L3MBTL1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11958971-B2 | Photocurable composition, method for producing concave-convex structure, method for forming fine concave-convex pattern, and concave-convex structure | MITSUI CHEMICALS, INC. (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-110741463-B | Method for producing substrate with fine concave-convex pattern, resin composition, and laminate | 三井化学株式会社 | 2024-02-20 | — | — | CN | disclosed |
| CN-113574086-B | Photocurable composition, method for producing uneven structure, method for forming fine uneven pattern, and uneven structure | 三井化学株式会社 | 2023-11-07 | — | — | CN | disclosed |
| US-11597910-B2 | Medical instrument, cell culture method, fluorine-containing cyclic olefin polymer and fluorine-containing cyclic olefin polymer composition for it, and cultured cells | MITSUI CHEMICALS, INC. (JP) | 2023-03-07 | — | — | US | disclosed |
| US-11474429-B2 | Method of producing substrate with fine uneven pattern, resin composition, and laminate | MITSUI CHEMICALS, INC. (JP) | 2022-10-18 | — | — | US | disclosed |
| EP-3998298-A1 | PHOTOCURABLE COMPOSITION, PRODUCTION METHOD FOR UNEVEN STRUCTURAL BODY, METHOD FOR FORMING MINUTE UNEVEN PATTERN, AND UNEVEN STRUCTURAL BODY | Mitsui Chemicals, Inc. (JP) | 2022-05-18 | — | — | EP | disclosed |
| US-20220135787-A1 | PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CONCAVE-CONVEX STRUCTURE, METHOD FOR FORMING FINE CONCAVE-CONVEX PATTERN, AND CONCAVE-CONVEX STRUCTURE | MITSUI CHEMICALS, INC. (JP) | 2022-05-05 | — | — | US | disclosed |
| CN-113574086-A | Photocurable composition, method for producing uneven structure, method for forming fine uneven pattern, and uneven structure | 三井化学株式会社 | 2021-10-29 | — | — | CN | disclosed |
| CN-107429210-B | Medical device, fluorine-containing cyclic olefin polymer composition, and cell culture method | 三井化学株式会社 | 2021-05-28 | — | — | CN | disclosed |
| US-20200338807-A1 | METHOD FOR PRODUCING CONCAVE-CONVEX STRUCTURE, LAMINATE TO BE USED IN METHOD FOR PRODUCING CONCAVE-CONVEX STRUCTURE, AND METHOD FOR PRODUCING LAMINATE | MITSUI CHEMICALS, INC. (JP) | 2020-10-29 | — | — | US | disclosed |
| US-20110217651-A1 | IMAGE FORMATION METHOD AND IMAGE FORMATION APPARATUS | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2011-09-08 | — | — | US | disclosed |
| EP-2033982-A1 | RESIN COMPOSITION FOR STEREOLITHOGRAPHY | Cmet Inc. (JP) | 2009-03-11 | — | — | EP | disclosed |
| US-7238763-B2 | Unsaturated monocarboxylic ester compounds | KANAGAWA UNIVERSITY AND TAIYO INK MANUFACTURING CO., LTD. (JP) | 2007-07-03 | — | — | US | disclosed |
| EP-1251118-B1 | UNSATURATED MONOCARBOXYLIC ESTER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION CURABLE WITH ACTINIC ENERGY RAY | UNIV KANAGAWA (JP) | 2006-12-20 | — | — | EP | disclosed |
| US-7057063-B2 | Unsaturated carboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | KANAGAWA UNIVERSITY (JP) | 2006-06-06 | — | — | US | disclosed |
| EP-1632794-A2 | Radiation sensitive resin composition for forming microlens | JSR Corporation (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-20060030636-A1 | Unsaturated carboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | KANAGAWA UNIVERSITY | 2006-02-09 | — | — | US | disclosed |
| US-20060008735-A1 | Radiation sensitive resin composition for forming microlens | JSR CORPORATION (JP) | 2006-01-12 | — | — | US | disclosed |
| US-20030009053-A1 | Unsaturated monocarboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | KANAGAWA UNIVERSITY (JP) | 2003-01-09 | — | — | US | disclosed |
| EP-1251118-A1 | UNSATURATED MONOCARBOXYLIC ESTER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION CURABLE WITH ACTINIC ENERGY RAY | Kanagawa University (JP) | 2002-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030009053-A1 | Unsaturated monocarboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | ACSL1, ACSL6, ACSL4 | ALDH1A1 585/4885CYP3A4 1395/4885L3MBTL1 2474/4885 |
| US-20060030636-A1 | Unsaturated carboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | ACSL1, ACSL6, ACSL3 | ALDH1A1 467/4885CYP3A4 1520/4885L3MBTL1 2717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.